Physician profile
Kyle James Viola
NPI 1689102014
$1,257.82
in general payments reported to CMS, 2019-2025
18 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $501 · 2022: $294 · 2023: $290 · 2024: $18.47 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $270.76 | 2021-2022 | |
| Seapearl East, INC | $155.57 | 2022-2023 | |
| Glaxosmithkline, LLC. | $147.31 | 2021 | |
| Myriad Women'S Health, INC. | $128.66 | 2023 | Myrisk |
| Biohaven Pharmaceuticals, INC. | $123.85 | 2021 | |
| Abbvie INC. | $89.55 | 2021 | |
| Nalu Medical, INC. | $62.81 | 2025 | Nalu Neurostimulation System |
| Gilead Sciences, INC. | $57.28 | 2021 | |
| Exact Sciences Corporation | $50.64 | 2024-2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $30.82 | 2021-2022 | |
| Medtronic, INC. | $23.63 | 2025 | Inceptiv |
| Otsuka America Pharmaceutical, INC. | $21.15 | 2023 | Rexulti |
| Vertex Pharmaceuticals Incorporated | $20.07 | 2025 | |
| Genentech USA, INC. | $18.65 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.94 | 2025 | Gvoke Hypopen |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.49 | 2021 | |
| Novo Nordisk INC | $13.83 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Viola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.